Abstract
A wide range of sources supports that the link between diet and colorectal cancer may be due to an imbalance of the intestinal microflora. In this case, it seems that the probiotics may have a possible molecular mechanism via microRNAs (miRNAs). The present study is aimed to evaluate the effects of Lactobacillus acidophilus and Bifidobacterium bifidum probiotics on the expression of miRNAs 135b, 26b, 18a, and 155 and their target genes, including APC, PTEN, KRAS, and PU.1 in mouse azoxymethane (AOM)-induced colon cancer. Thirty-eight male BALB/c mice were randomly divided into four groups: the control, AOM, Lactobacillus acidophilus, and Bifidobacterium bifidum to deliberate the effects of the probiotics on the miRNAs and their target genes. Except for the control group, the rest groups were weekly given AOM (15 mg/kg, s.c) in three consecutive weeks to induce mouse colon cancer. The animals were given 1.5 g powders of L. acidophilus (1 × 109 cfu/g) and B. bifidum (1 × 109 cfu/g) in 30 cc drinking water in the related groups for 5 months. At the end of the study, the animals were sacrificed and their blood and colon samples were removed for the molecular analyses. The results showed that the expression of the miR-135b, miR-155, and KRAS was increased in the AOM group compared to the control group in both the plasma and the colon tissue samples, and the consumption of the probiotics decreased their expression. Moreover, the miR-26b, miR-18a, APC, PU.1, and PTEN expressions were decreased in the AOM group compared to the control group and the consumption of the probiotics increased their expressions. It seems that Lactobacillus acidophilus and Bifidobacterium bifidum though increasing the expression of the tumor suppressor miRNAs and their target genes and decreasing the oncogenes can improve colon cancer treatment.
Similar content being viewed by others
References
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
Rafter J (2004) The effects of probiotics on colon cancer development. Nutr Res Rev 17(2):277–284
Uccello M, Malaguarnera G, Basile F, D'Agata V, Malaguarnera M, Bertino G, Vacante M, Drago F, Biondi A (2012) Potential role of probiotics on colorectal cancer prevention. BMC Surg 12(Suppl 1):S35. https://doi.org/10.1186/1471-2482-12-S1-S35
Hotel ACP (2001) Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Cordoba, Argentina
Iannitti T, Palmieri B (2010) Therapeutical use of probiotic formulations in clinical practice. Clin Nutr 29(6):701–725
Quigley EM (2010) Prebiotics and probiotics; modifying and mining the microbiota. Pharmacol Res 61(3):213–218
Grajek W, Olejnik A, Sip A (2005) Probiotics, prebiotics and antioxidants as functional foods. Acta Biochim Pol 52(3):665–671
Ranji P, Akbarzadeh A, Rahmati-Yamchi M (2015) Associations of probiotics with vitamin D and leptin receptors and their effects on colon cancer. Asian Pac J Cancer Prev 16(9):3621–3627
Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, Reddy BS (1997) Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18(4):833–841
Agah S, Alizadeh AM (2018) More protection of Lactobacillus acidophilus than Bifidobacterium bifidum probiotics on azoxymethane-induced mouse colon cancer. Probiotics Antimicrob Proteins. https://doi.org/10.1007/s12602-018-9425-8
Khavari-Daneshvar H, Mosavi M, Khodayari H, Rahimi E, Ranji P, Mohseni AH, Mahmudian R, Shidfar F, Agah S, Alizadeh AM (2017) Modifications of mice gut microflora following oral consumption of Lactobacillus acidophilus and Bifidobacterium bifidum probiotics. Turk J Med Sci 47(2):689–694
Ohland CL, MacNaughton WK (2010) Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol 298(6):G807–G819
Kreuzer-Redmer S, Bekurtz JC, Arends D, Bortfeldt R, Kutz-Lohroff B, Sharbati S, Einspanier R, Brockmann GA (2016) Feeding of Enterococcus faecium ncimb 10415 leads to intestinal miRNA-423-5p-induced regulation of immune-relevant genes. Appl Environ Microbiol 82(8):2263–2269
Schetter AJ, Harris CC (2009) Plasma microRNAs: a potential biomarker for colorectal cancer? Gut 58(10):1318–1319
Slaby O, Svoboda M, Michalek J, Vyzula R (2009) MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 8:102. https://doi.org/10.1186/1476-4598-8-102
Farsinejad S, Rahaie M, Alizadeh AM, Mir-Derikvand M, Gheisary Z, Nosrati H, Khalighfard S (2016) Expression of the circulating and the tissue microRNAs after surgery, chemotherapy, and radiotherapy in mice mammary tumor. Tumor Biol 37(10):14225–14234
Khori V, Alizadeh AM, Gheisary Z, Farsinejad S, Najafi F, Khalighfard S, Ghafari F, Hadji M, Khodayari H (2016) The effects of low-level laser irradiation on breast tumor in mice and the expression of let-7a, miR-155, miR-21, miR125, and miR376b. Lasers Med Sci 31(9):1775–1782
Thomas J, Ohtsuka M, Pichler M, Ling H (2015) MicroRNAs: clinical relevance in colorectal cancer. Int J Mol Sci 16(12):28063–28076
Rabiee-Ghahfarrokhi B, Rafiei F, Niknafs AA, Zamani B (2015) Prediction of microRNA target genes using an efficient genetic algorithm-based decision tree. FEBS open bio 5:877–884
Endzelins E, Berger A, Melne V, Bajo-Santos C, Sobolevska K, Abols A, Rodriguez M, Santare D, Rudnickiha A, Lietuvietis V (2017) Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients. BMC Cancer 17(1):730. https://doi.org/10.1186/s12943-016-0523-5
Ristau J, Staffa J, Schrotz-King P, Gigic B, Makar KW, Hoffmeister M, Brenner H, Ulrich A, Schneider M, Ulrich CM (2014) Suitability of circulating miRNAs as potential prognostic markers in colorectal cancer. Cancer Epidemiol Biomark Prev 23(12):2632–2637
Alizadeh AM, Khaniki M, Azizian S, Mohaghgheghi MA, Sadeghizadeh M, Najafi F (2012) Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier-curcumin. Eur J Pharmacol 689(1–3):226–232
Isanejad A, Alizadeh AM, Shalamzari SA, Khodayari H, Khodayari S, Khori V, Khojastehnjad N (2016) MicroRNA-206, let-7a and microRNA-21 pathways involved in the anti-angiogenesis effects of the interval exercise training and hormone therapy in breast cancer. Life Sci 151:30–40
Khori V, Shalamzari SA, Isanejad A, Alizadeh AM, Alizadeh S, Khodayari S, Khodayari H, Shahbazi S, Zahedi A, Sohanaki H (2015) Effects of exercise training together with tamoxifen in reducing mammary tumor burden in mice: possible underlying pathway of miR-21. Eur J Pharmacol 765:179–187
Sharbati-Tehrani S, Kutz-Lohroff B, Bergbauer R, Scholven J, Einspanier R (2008) miR-Q: a novel quantitative RT-PCR approach for the expression profiling of small RNA molecules such as miRNAs in a complex sample. BMC Mol Biol 9:34. https://doi.org/10.1186/1471-2199-9-34
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45
Nagel R, le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, Bolijn A, Meijer GA, Agami R (2008) Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 68(14):5795–5802
Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzo M, Garcia-Foncillas J (2006) Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5:29. https://doi.org/10.1186/1476-4598-5-29
Xu XM, Qian JC, Deng ZL, Cai Z, Tang T, Wang P, Zhang KH, Cai JP (2012) Expression of miR-21, miR-31, miR-96, and miR-135b is correlated with the clinical parameters of colorectal cancer. Oncol Lett 4(2):339–345
Fodde R (2002) The APC gene in colorectal cancer. Eur J Cancer 38(7):867–871
Shimizu Y, Ikeda S, Fujimori M, Kodama S, Nakahara M, Okajima M, Asahara T (2002) Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosomes and Cancer 33(1):73–81
Thompson RC, Herscovitch M, Zhao I, Ford TJ, Gilmore TD (2010) NF-κB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway. J Biol Chem 286(3):1675–1682
Naser WM, Shawarby MA, Al-Tamimi DM, Seth A, Al-Quorain A, Al Nemer AM, Albagha OM (2014) Novel KRAS gene mutations in sporadic colorectal cancer. PLoS One 9(11):e113350. https://doi.org/10.1371/journal.pone.0113350
Vigorito E Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S, Das PP, Miska EA, Rodriguez A, Bradley A, Smith KG, Rada C, Enright AJ, Toellner KM, Maclennan IC, Turner M (2007) MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27:847–859
DeKoter RP, Singh H (2000) Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288(5470):1439–1441
Martinez-Nunez RT, Louafi F, Friedmann PS, Sanchez-Elsner T (2009) MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J Biol Chem 284(24):16334–16342
Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, Kroesen BJ, van den Berg A (2005) BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207(2):243–249
Xie H, Ye M, Feng R, Graf T (2004) Stepwise reprogramming of B cells into macrophages. Cell 117(5):663–676
Palumbo T, Faucz FR, Azevedo M, Xekouki P, Iliopoulos D, Stratakis CA (2013) Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway. Oncogene 32(13):1651–1659
Zhang C, Tong J, Huang G (2013) Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells. PLoS One 8(7):e69963. https://doi.org/10.1371/journal.pone.0069963
Zeitels LR, Acharya A, Shi G, Chivukula D, Chivukula RR, Anandam JL, Abdelnaby AA, Balch GC, Mansour JC, Yopp AC, Richardson JA, Mendell JT (2014) Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis. Genes Dev 28(23):2585–2590
Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, Pandolfi PP (2001) PTEN and p27kip1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet 27(2):222–224
Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R (1999) Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A 96(4):1563–1568
Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, Xiao A, Khoo AS, Roy-Burman P, Greenberg NM, Van Dyke T, Cordon-Cardo C, Pandolfi PP (2003) PTEN dose dictates cancer progression in the prostate. PLoS Biol 1(3):E59. https://doi.org/10.1371/journal.pbio.0000059
Tsang WP, Kwok TT (2009) The miR-18a microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis 30(6):953–959. https://doi.org/10.1093/carcin/bgp094
Banno K, Kisu I, Yanokura M, Tsuji K, Masuda K, Ueki A, Kobayashi Y, Yamagami W, Nomura H, Tominaga E, Susumu N, Aoki D (2012) Biomarkers in endometrial cancer: possible clinical applications (review). Oncol Lett 3(6):1175–1180
Tsunoda T, Takashima Y, Yoshida Y, Doi K, Tanaka Y, Fujimoto T, Machida T, Ota T, Koyanagi M, Kuroki M, Sasazuki T, Shirasawa S (2011) Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells. Anticancer Res 31(7):2453–2459
Yau T, Wu C, Dong Y, Tang C, Ng S, Chan F, Sung J, Yu J (2014) MicroRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma. Br J Cancer 111(9):1765–1771
Hiraki M, Nishimura J, Takahashi H, Wu X, Takahashi Y, Miyo M, Nishida N, Uemura M, Hata T, Takemasa I, Mizushima T, Soh JW, Doki Y, Mori M, Yamamoto H (2015) Concurrent targeting of KRAS and AKT by miR-4689 is a novel treatment against mutant KRAS colorectal cancer. Mol Ther Nucleic Acids 4:e231. https://doi.org/10.1038/mtna.2015.5
Gill RK, Dudeja PK (2011) A novel facet to consider for the effects of butyrate on its target cells. Focus on “the short-chain fatty acid butyrate is a substrate of breast cancer resistance protein”. Am J Physiol Cell Physiol 301(5):C977–C979. https://doi.org/10.1152/ajpcell.00290.2011
Funding
This study was supported by Iran University of Medical Sciences (Grant No. 24067).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethical Approval
All procedures performed in studies involving animals were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Conflict of Interest
The authors of the manuscript have no conflicts of interest to declare and are responsible for the content of the paper.
Disclaimer
None of the funding sources had any role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.
Rights and permissions
About this article
Cite this article
Heydari, Z., Rahaie, M., Alizadeh, A.M. et al. Effects of Lactobacillus acidophilus and Bifidobacterium bifidum Probiotics on the Expression of MicroRNAs 135b, 26b, 18a and 155, and Their Involving Genes in Mice Colon Cancer. Probiotics & Antimicro. Prot. 11, 1155–1162 (2019). https://doi.org/10.1007/s12602-018-9478-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12602-018-9478-8